Premium
The phylogenetic approach for viral infectious disease evolution and epidemiology: An updating review
Author(s) -
Ciccozzi Massimo,
Lai Alessia,
Zehender Gianguglielmo,
Borsetti Alessandra,
Cella Eleonora,
Ciotti Marco,
Sagnelli Evangelista,
Sagnelli Caterina,
Angeletti Silvia
Publication year - 2019
Publication title -
journal of medical virology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.782
H-Index - 121
eISSN - 1096-9071
pISSN - 0146-6615
DOI - 10.1002/jmv.25526
Subject(s) - phylogenetic tree , coalescent theory , biology , infectious disease (medical specialty) , phylogenetics , molecular epidemiology , viral phylodynamics , virology , outbreak , chikungunya , dengue fever , evolutionary biology , population , phylogeography , pandemic , genomics , disease , genetics , genome , medicine , genotype , covid-19 , gene , environmental health , pathology
In the last decade, the phylogenetic approach is recurrent in molecular evolutionary analysis. On 12 May, 2019, about 2 296 213 papers are found, but typing “phylogeny” or “epidemiology AND phylogeny” only 199 804 and 20 133 are retrieved, respectively. Molecular epidemiology in infectious diseases is widely used to define the source of infection as so as the ancestral relationships of individuals sampled from a population. Coalescent theory and phylogeographic analysis have had scientific application in several, recent pandemic events, and nosocomial outbreaks. Hepatitis viruses and immunodeficiency virus (human immunodeficiency virus) have been largely studied. Phylogenetic analysis has been recently applied on Polyomaviruses so as in the more recent outbreaks due to different arboviruses type as Zika and chikungunya viruses discovering the source of infection and the geographic spread. Data on sequences isolated by the microorganism are essential to apply the phylogenetic tools and research in the field of infectious disease phylodinamics is growing up. There is the need to apply molecular phylogenetic and evolutionary methods in areas out of infectious diseases, as translational genomics and personalized medicine. Lastly, the application of these tools in vaccine strategy so as in antibiotic and antiviral researchers are encouraged.